Evaluating the WHO Assessment Instrument for Mental Health Systems by comparing mental health policies in four countries
Hamada Hamid, Karen Abanilla, Besa Bauta, Keng-Yen Huang
Volume 86, Number 6, June 2008, 467-473
Table 2. Sample items WHO-AIMS
| Item | Detail |
|---|---|
| Definition | Proportion of mental hospitals with at least one-day training, meeting or other type of working session on human rights protection of patients in the last two years |
| Measure | Proportion; UN = unknown; NA = non applicable |
| Numerator | Number of mental hospitals with at least one-day training, meeting or other type of working session on human rights protection of patients in the last two years |
| Denominator | Total number of mental hospitals (#) |
| Definition | Proportion of community-based inpatient psychiatric units and community residential facilities with at least one-day training, meeting or other type of working session on human rights protection of patients in the last two years |
| Measure | Proportion; UN = unknown; NA = non applicable |
| Numerator | Number of community-based inpatient psychiatric units and community residential facilities with at least one-day training, meeting or other type of working session on human rights protection of patients in the last two years |
| Denominator | Total number of community-based inpatient psychiatric units and community residential facilities (#) |
| Definition | Proportion of population with free access (at least 80% covered) to essential psychotropic medicines |
| Measure | Proportion; UN = unknown; NA = non applicable |
| Numerator | Number of people with free access (at least 80% covered) to essential psychotropic medicines |
| Denominator | Number of people in general population |
| Notes | This item is specific for psychotropic drugs (in many countries psychotropic drugs are not covered by government or insurance schemes)Free access to essential psychotropic medicines means that essential psychotropics – once prescribed – are provided to people with mental disorders free of cost or with reimbursement equal or more than 80% of the retail price. The funding sources for free access/reimbursement may be the government or insurance schemes (employment, social or private) |
| Definition | Proportion of mental health outpatient facilities in which at least one psychotropic medicine of each therapeutic category (antipsychotic, antidepressant, mood stabilizer, anxiolytic and antiepileptic medicines) is available in the facility or in a nearby pharmacy all year long |
| Measure | Proportion; UN = unknown; NA = non applicable |
| Numerator | Number of mental health outpatient facilities in which at least one psychotropic medicine of each therapeutic category is available in the facility or in a nearby pharmacy |
| Denominator | Total number of mental health outpatient facilities (#) |
WHO-AIMS, WHO Assessment Instrument for Mental Health Systems.